Navigation Links
PLUS Diagnostics Introduces Industry's First System to Eliminate Misidentification of Bone Marrow Samples
Date:6/3/2010

UNION, N.J., June 3 /PRNewswire/ -- For the first time, patients being tested for leukemia, lymphoma, and other blood and bone marrow malignancies can be certain that their test results are their own and not those of another patient. PLUS Diagnostics, a leading anatomic pathology company, announced today that it has introduced the industry's first system to eliminate misidentification and matching errors of bone marrow biopsy samples.

The median rate for specimen misidentification among U.S. health care providers including physician offices is as high as 1.31 for every 1,000 specimens, according to a 2008 study conducted by the College of American Pathologists. The national press has highlighted several incidents in the past year in which patients have received incorrect cancer diagnoses and treatment, or lack of treatment, because their samples were mismatched with someone else's samples.

"The consequences of misidentifying or mismatching a bone marrow sample are irrevocable. Undergoing a bone marrow biopsy procedure is incredibly painful.

Receiving an incorrect diagnosis because that biopsy sample was mismatched is traumatic at best and can be deadly at worst," said Dave Pauluzzi, president and COO, PLUS Diagnostics. "By introducing this new system, PLUS has taken another step toward enhancing patient safety throughout the testing process, from drawing the sample in the physician's office to delivering it to the laboratory for testing, to ensure that doctors and their patients can have the highest levels of confidence in their results."

The new system, know error™, matches DNA from a buccal swab taken during the biopsy procedure with bone marrow or blood provided to PLUS Diagnostics for testing. The system is PLUS Diagnostics' latest innovation since it partnered with Water Street Healthcare Partners, a leading private equity firm focused exclusively on healthcare. Over the past two years, the company has invested in building bi-coastal laboratories and introducing new tests that diagnose a broad scope of cancers and diseases.

"Our focus is providing physicians and specialists with innovative services that meet their unique needs," said Pauluzzi. "We are constantly searching for and investing in the newest science and technologies that will support them with achieving the best possible outcomes for their patients."

About PLUS Diagnostics

PLUS Diagnostics is a leading national anatomic pathology company that provides a full range of multi-specialty services, including extensive diagnostic procedures and specialist consultations. Accredited by the College of American Pathologists, PLUS Diagnostics has long been recognized for exceptional service and quality. The company currently focuses on a broad base of specialty pathology services, including urology, gastroenterology and hematology/oncology. For more information, visit www.plusdx.com.


'/>"/>
SOURCE PLUS Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Distinction of Quality for Dilon Diagnostics
2. Novartis Vaccines & Diagnostics to Pay More Than $72 Million to Resolve False Claims Act Allegations Concerning TOBI
3. Ambry Genetics and RainDance Technologies Announce Partnership for Diagnostics and Genomics Services Utilizing the RDT 1000 for Sequence Enrichment and Targeted Resequencing Validation
4. Home Diagnostics Selects Parago to Deliver Consumer Incentives Focused on Best Customer Experience
5. Dilon Diagnostics Receives ISO 13485 Certification
6. Quest Diagnostics Unveils Care360(TM) EHR
7. PRA International Hosts a Late Phase Services Webinar Establishing Value for Diagnostics & Biomarkers in a Real-Life Setting
8. Exagen Diagnostics Enters Into Exclusive Agreement With EndoChoice
9. AstraZeneca and Dako Sign Agreement to Develop Companion Diagnostics for Cancer Treatments
10. Sword Diagnostics Announces Availability of Proprietary Detection Technology for Ultrasensitive Immunoassays.
11. Inverness Medical Innovations Offers to Acquire Standard Diagnostics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/25/2016)... , May 25, 2016  Zymo Research ... for their new reference materials that help researchers ... sample collection to analyses. The rapid growth of ... for researchers to have standard methods to improve ... generated. Biases inherently exist at every step of ...
(Date:5/25/2016)... , May 25, 2016  Granger Diagnostics today announced ... for wounds and infections. This test ensures discovery ... select viruses. The test requires only a simple swab ... David G. Bostwick , MD, Chief ... facilitate wound healing: "We are excited to make ...
(Date:5/25/2016)... , May 25, 2016 ... 2016"market research report that provides an overview on ... analysis at various stages, therapeutics assessment by drug ... (RoA) and molecule type, along with latest updates, ... reviews key players involved in the therapeutic development ...
Breaking Medicine Technology:
(Date:5/27/2016)... ... May 27, 2016 , ... Aimed at nurses and employees ... which come courtesy of leaders in the nursing and health care industry. It also ... and associations—namely Abilene Christian University. , As the nursing industry is coming out ...
(Date:5/26/2016)... , ... May 26, 2016 , ... Despite last week’s ... expect Janet Yellen and company to wait until March 2017 for an interest rate ... J. Mack Robinson College of Business. , “The Federal Open Market Committee (FOMC) dot ...
(Date:5/26/2016)... ... May 26, 2016 , ... ... of thousands of defective respirators, according to court documents and SEC filings. ... William and Becky Tyler v. American Optical Corporation, Case No. BC588866, Los Angeles ...
(Date:5/26/2016)... ... May 26, 2016 , ... Connor Sports, through its ... partner for the Tamika Catchings Legacy Tour that will commemorate the Indiana ... hardwood basketball surfaces in all forms and levels of the game, Connor Sports has ...
(Date:5/26/2016)... ... May 26, 2016 , ... Cardiac arrhythmia is a common ... long-term patient survival, reports a team of UPMC researchers in the largest study ... Journal of Thoracic and Cardiovascular Surgery, provide critical information that will hopefully lead ...
Breaking Medicine News(10 mins):